EXECUTIVE SUMMARY
UNFPA is actively building corporate and innovative partnership models beyond traditional ODA. This document maps the emerging partnership landscape — from the Coalition for Reproductive Justice in Business to impact bonds, gender lens investing vehicles, and digital health platforms — providing UNFPA staff with concrete models and talking points for conversations with private sector partners.
UNFPA'S CORPORATE PARTNERSHIP ARCHITECTURE
Coalition for Reproductive Justice in Business (CRJB)
Launched in Asia-Pacific on 15 May 2025 in Bangkok, co-hosted with Organon Thailand. The CRJB represents UNFPA's most ambitious corporate engagement initiative.
What it is: A global business coalition establishing the first-ever corporate metrics for SRHR, developed with Accenture. Framework of 30 indicators across six areas: menstruation/menopause support, family planning benefits, GBV protection, maternal health, reproductive health education, and workplace accommodations.
Corporate participants (Asia-Pacific launch):
- IKEA India: Workplace SRHR integration
- John Keells Holdings (Sri Lanka): Corporate SRHR programme
- SM Cares (Philippines): Community health initiative
- Shahi Exports (India): Satellite clinics near factories; biometric sanitary napkin access — formalised UNFPA partnership October 2025
- TATA Motors (India): Workplace health programme
- Organon Thailand: Co-host and pharmaceutical partner
2019 Nairobi Summit: Private sector pledges totalled $8 billion toward ending maternal deaths and GBV by 2030.
Talking point for corporate funders: "The CRJB provides the first standardised framework for measuring corporate impact on women's reproductive health. Companies joining now are establishing themselves as leaders in a space that ESG frameworks are beginning to require reporting on."
WomenX Collective
Launched at the World Health Summit 2024 in Berlin. UNFPA's flagship health innovation partnership.
- Target: Raise USD 100 million by 2030 for innovative health solutions for underserved communities in LMICs
- Focus: Reproductive and maternal health innovation
- Initial funders: CIFF (Children's Investment Fund Foundation), Organon & Co., Deutsche Postcode Lotterie
- Structure: Combines philanthropic grants with innovation funding
Talking point: "WomenX Collective is UNFPA's innovation arm — backing the next generation of women's health solutions. Partners become part of a global portfolio of health innovations with measurable impact."
UNFPA Supplies Partnership
UNFPA's longest-standing partnership model — the world's largest multilateral contraceptive procurement mechanism.
- 2024 procurement: USD 516 million total; USD 214 million in contraceptives alone
- Countries served: 54 lowest-income countries through the Supplies Partnership; 120+ total through procurement services
- 39 of 54 Supplies Partnership countries are in humanitarian/fragile settings
- Cost savings: 20–40% below private market prices through pooled procurement power
- Since 2011: 80 programme countries and 50 partners have procured through UNFPA
- Domestic ownership growth: Government expenditure on contraceptives in programme countries grew from $10.4M (2020) to $52 million (2024) — a 5x increase
Talking point: "UNFPA's procurement power is unmatched. For every dollar invested in contraceptive procurement through UNFPA, the cost savings alone generate immediate, measurable returns. Domestic government co-financing has grown 5x in four years — proving the sustainability model works."
IMPACT BONDS AND OUTCOMES-BASED FINANCING
The Utkrisht Experience: Lessons from the World's First Maternal Health DIB
Final results (completed 2022):
- 405 private facilities in Rajasthan accredited to maternal/neonatal quality standards
- 13,449 maternal and neonatal deaths averted (Lives Saved Tool modelling)
- 11.79 million women of reproductive age reached
- $9 million total: UBS Optimus Foundation (investor), USAID and MSD for Mothers (outcome funders), PSI/Palladium/HLFPPT (implementers)
- Completed on time despite COVID-19
Limitation: No formal counterfactual impact evaluation; lives-saved figures are model-based projections.
Current State of Health DIBs in Asia
- No new health DIBs launched in Asia 2024–2026
- Global total: 300 impact bonds tracked (INDIGO, November 2024); only 10 in health in LMICs
- Impact bonds for RMNCAH represent 25% of solutions despite being <5% of SDG 3-aligned blended finance
- The Cambodia Rural Sanitation DIB (completed 2023): 1.7 million people, fully repaid — successful WASH model
Emerging Opportunities
- World Bank West Bengal (January 2026): $286M outcomes-linked programme for NCD management — largest outcomes-based health financing in India
- OECD mainstreaming OBF (2025): New guidance estimating total OBF may exceed $100 billion globally
- Pakistan's first DIB in development (British Asian Trust/ADB) — targets women's employment
- DAH decline (from $80.3B peak to $49.6B in 2024) creating pressure for results-linked financing
Talking point for impact investors: "The Utkrisht DIB proved that maternal health outcomes are measurable and achievable at scale. The model is proven but hasn't been replicated — because no one has structured the next one. That's the opportunity."
GENDER LENS INVESTING VEHICLES
Market Context
- Global GLI: $67.5–122 billion (2024-2025)
- 2X Challenge: $20 billion pledged for 2024–2027; cumulative $33.6B since 2018
- Asia is second-largest GLI region: $1.4 billion across 47 vehicles
- Gender-diverse funds: 20% higher net IRR in emerging markets
Key Vehicles for UNFPA Engagement
Sweef Capital (Singapore):
- Pure-play gender lens investor; ~$45M debut fund
- Proprietary Gender ROI framework
- Backed by AIIB, PayPal, Danish pension fund PBU
- Portfolio in Vietnam (Teky Academy, USM Healthcare)
Impact Investment Exchange (IIX) (Singapore):
- Women's Livelihood Bond 5: $50M listed on Singapore Exchange
- $128M+ mobilised across five "orange bond" series
- Zero reported losses
Global Gender-Smart Fund (GGSF):
- Launched January 2024 (converted from 15-year-old Microfinance Enhancement Facility)
- Managed by Innpact and Sarona Asset Management
- Targets $1.7 trillion gender finance gap
Australian Development Investments (ADI):
- AUD 250M (~$168M) with dual climate-and-gender mandate
- Managed by Sarona; mobilisation ratio exceeds 1:6
- Investing in Asia-Pacific funds
How UNFPA Connects to GLI
UNFPA's three transformative results are definitionally gender outcomes. The connection:
- SRHR as foundation for women's economic participation: Family planning access enables women's workforce entry
- GBV prevention as business productivity: Workplace safety programmes reduce absenteeism
- Maternal health as human capital investment: Healthy mothers = healthy economies
- Only 0.2% of global R&D targets SRHR in developing countries — massive underinvestment
DIGITAL HEALTH AND INNOVATION PARTNERSHIPS
UNFPA Innovation Strategy (January 2025)
UNFPA published its Innovation Strategy, signalling a push toward technology partnerships for SRHR delivery.
Working Models in Asia
SoSafe (Thailand):
- Partnership with TraffyFondue civic tech app
- Digital GBV and teenage pregnancy reporting platform
- Results: 1,000+ cases addressed, 6,000+ officials trained across 14 provinces, 580,000+ reached
- National expansion planned
Monpi Coffee Partnership (Papua New Guinea):
- UNFPA partnered with Monpi Coffee Exports Ltd. (largest PNG Highlands coffee exporter)
- SRHR integrated into coffee-growing communities
- 4,600+ farmers reached, including financial guarantee scheme for health
- Model: embed SRHR in existing commercial value chains
Digital Sexuality Education:
- 93 content creators trained across 12 Asia-Pacific countries in 2024
- Reaching adolescents through platforms they already use
Technology Partnership Opportunity
For tech companies and foundations: UNFPA needs digital infrastructure for community health worker communication during climate disruptions, mobile contraceptive supply chain management, GBV case referral systems, and data analytics for climate-SRHR monitoring. These are concrete, buildable technology products.
UNFPA MIDWIFERY: THE COST-EFFECTIVENESS POWERHOUSE
The Shortage
- Global midwife shortage: approximately 900,000 (SoWMy 2021)
- State of Asia's Midwifery 2024 Report published covering 21 countries
- Scaling midwifery to universal coverage by 2035 could avert 65% of stillbirths (Western Pacific data)
- UNFPA supported only 47% of intended midwives in crisis settings after funding cuts
Cost-Effectiveness Evidence
Midwifery is one of the highest-return health investments:
- Midwife-led care reduces preterm births, stillbirths, and neonatal deaths
- Community midwives provide the skilled birth attendance that prevents the 40%+ of stillbirths occurring during labour
- In fragile settings, midwives are the health system's last line of defence
Talking point: "Midwives are the highest-return health investment UNFPA makes. For the cost of training and deploying one midwife for a year, dozens of maternal and neonatal deaths are prevented. We need 900,000 more globally — and right now, we can't even fund half of those we've already committed to in crisis settings."
MAJOR PHILANTHROPIC PARTNERSHIPS
Gates Foundation
- $2.5 billion through 2030 for women's health R&D in LMICs — largest such commitment ever
- Five areas: obstetric care, maternal health, gynaecological/menstrual health, contraceptive innovation, STI treatment
- 40+ innovations supported
- Foundation will sunset by 2045 with $200 billion total giving pledge
- Co-leads PAA Health for Human Potential community ($100M target by 2030)
- $1.6 billion pledged to Gavi 6.0
Melinda French Gates / Pivotal
- Action for Women's Health: $250 million global open call (2024)
- Distributing $1–5M grants to 80+ organisations working on women's health
DBS Foundation (Singapore)
- SGD 1 billion over 10 years commitment (from 2024); ~SGD 100M/year
- 2024 deployment: SGD 88 million across 15 multi-year initiatives
- Targeting 9.8 million beneficiaries by 2027
- Since 2015: SGD 21.5M in grants to 160+ social enterprises
- DBS Multi Family Office Foundry VCC reached SGD 1B AUM
AIIB
- Cumulative financing: nearly $70 billion across 361 projects
- 67% climate finance share ($5.6B of $8.4B in 2024)
- Gender strategy in place but no SRHR-specific projects identified
- Sweef Capital is an AIIB-backed fund — demonstrating AIIB willingness to invest through gender lens vehicles
SOURCES
- UNFPA CRJB regional launch announcement (May 2025)
- UNFPA WomenX Collective launch (World Health Summit 2024)
- UNFPA Supplies Partnership annual reports
- GO Lab Oxford: Utkrisht Impact Bond case study; INDIGO dataset
- Brookings: Impact Bonds by the Numbers
- 2X Global: 2X Challenge G7 announcements (2024)
- Sweef Capital: 2024 Impact Report
- IIX: Women's Livelihood Bond documentation
- Gates Foundation: August 2025 women's health commitment
- DBS Foundation: 2024 annual report; SGD 1B commitment
- AIIB: 2024 Annual Report
- UNFPA Asia-Pacific Annual Report 2024
Evidence quality rating: Strong on financial figures (official reports). Strong on CRJB framework (published 2024 policy paper). Strong on Utkrisht results (independent evaluation). Moderate on partnership feasibility (mandate alignment analysis). Moderate on innovation models (early-stage, limited outcome data for digital platforms).